Circulating Tumor Cells Market Size Projected To Reach $21.68 Billion By 2034 With A Cagr Of 12.8%

The Circulating Tumor Cells Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Circulating Tumor Cells Market?
The market size of circulating tumor cells has experienced a swift growth in the recent past and is projected to continue this trend. It is anticipated to surge from $11.9 billion in 2024 to $13.37 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 12.4%. Factors contributing to this growth during the historic period include the increasing instances of cancer, the role of clinical utility in tracking cancer stages, the emergence of liquid biopsy, patients' preference for less invasive tests, regulatory endorsement for liquid biopsies, and an emphasis on the early detection of cancer.

The market size for circulating tumor cells is predicted to undergo substantial growth in the forthcoming years. By 2029, the industry is projected to expand to a worth of $21.68 billion, presenting a compound annual growth rate (CAGR) of 12.8%. Factors propelling this escalation during the projected period include the initiation of point-of-care CTC testing, the incorporation of microfluidics, emphasis on rare types of cancer, standardization of CTC assays, proliferation of CTC-related clinical trials, and the progress of booming and emergent markets. Key trends anticipated during this period comprise advancements in CTC isolation processes, government backing for CTC studies, broadening of CTC detection technologies, the application of liquid biopsy in cancer surveillance, incorporation of single-cell analysis, and technology amalgamation with Artificial Intelligence (AI).

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8950

What Are the Different Circulating Tumor Cells Market Segments?
The circulating tumor cells market covered in this report is segmented -

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems
2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis
3) By Specimen: Blood, Bone Marrow, Other Body Fluids
4) By Application: Clinical Or Liquid Biopsy, Research

Subsegments:
1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits
2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes
3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

What Are the Primary Drivers Shaping the Circulating Tumor Cells Market?
The escalating number of cancer cases is anticipated to stimulate the expansion of the circulating tumor cells market in the future. Cancer is described as a sickness where certain cells in the body multiply uncontrollably and proliferate to other parts. Circulating tumor cells play a pivotal role in the preliminary detection and diagnosis of cancer - as such, the mounting occurrence of cancer is fostering the growth of this market. For example, the American Cancer Society Journals, a US-based health volunteer organization, anticipated in January 2023 that there would be 1,958,310 fresh cancer cases, and 609,820 fatalities due to cancer expected in the United States. Thus, the increasing prevalence of cancer is largely fuelling the development of the circulating tumor cells market.

Which Companies Are Leading in the Circulating Tumor Cells Market?
Major companies operating in the circulating tumor cells market include Precision Medicine Group LLC, Bio-Techne Corporation, BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., Qiagen N.V., ScreenCell SAS, STEMCELL Technologies Inc., Sysmex Corporation, Aviva Biosciences Corporation, LungLife AI Inc., Miltenyi Biotec GmbH, Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, LineaRx Inc., Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Stanford Research Institute International, Agilent Technologies Inc., Resolution Bioscience Inc., Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd.

What Are the Major Trends Shaping the Circulating Tumor Cells Market?
The circulation of tumor cells market is witnessing growing popularity in the trend of product innovations. The major players in this market are concentrating on creating unique products to consolidate their market position. For instance, Bio-Rad Laboratories, Inc., a medical laboratory based in the US, unveiled the Celselect Slides 2.0 in June 2024. This product aims to improve the capture of rare cells and circulating tumor cells (CTCs), enhancing the precision and productivity of cell analysis for clinical research and applications.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

What Are the Top Revenue-Generating Geographies in the Circulating Tumor Cells Market?
North America was the largest region in the circulating tumor cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Circulating Tumor Cells Market?
2. What is the CAGR expected in the Circulating Tumor Cells Market?
3. What Are the Key Innovations Transforming the Circulating Tumor Cells Industry?
4. Which Region Is Leading the Circulating Tumor Cells Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.